Medical devices, healthcare technology and the business of care
510(k) clearance · K263182

EVO X30 Diagnostic Ultrasound System; EVO X20 Diagnostic Ultrasound System; EVO X10 Diagnostic Ultrasound System; EVO XP30 Diagnostic Ultrasound System; EVO XP20 Diagnostic Ultrasound System; EVO XP10 Diagnostic Ultrasound System; EVO XC30 Diagnostic Ultrasound System; EVO XC20 Diagnostic Ultrasound System; EVO XC10 Diagnostic Ultrasound System

Samsung Medison Co., Ltd. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK263182

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-25 for K263182, a traditional 510(k) from Samsung Medison Co., Ltd. covering nine EVO-series diagnostic ultrasound systems: the X30, X20, X10, XP30, XP20, XP10, XC30, XC20 and XC10. The application was received 09/11/2026 under regulation 892.1550, product code IYN, with subsequent codes ITX, IYO and LLZ, in the Radiology specialty and review panel. SESE denotes clearance to market, not PMA approval.

The record shows the review was conducted by a third party, with Regulatory Technology Services, LLC as correspondent and Prithul Bom as correspondent contact. A document excerpt states the EVO XC20 and EVO XC10 systems are substantially equivalent to the predicate device regarding intended use, imaging capabilities, technological characteristics and safety, but the full predicate identity, the specific changes from prior EVO models, and any performance data are not given in the available text.

The public page lists no summary statement, and the source does not identify which predicate device was cited or what, if anything, distinguishes these models from earlier clearances. No clinical, efficacy or labeling conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263182
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K263182 received

    Application receipt date recorded by FDA.

  2. K263182 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Samsung Medison Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hongcheon-Gun

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records